2014
DOI: 10.4103/0377-4929.142670
|View full text |Cite
|
Sign up to set email alerts
|

Molecular characterization of metallo β-lactamase producing multidrug resistant Pseudomonas aeruginosa from various clinical samples

Abstract: The prevalence of MBLs has been increasing worldwide, particularly among P. aeruginosa, leading to severe limitations in the therapeutic options for the management. Thus, proper resistance screening measures and appropriate antibiotic policy can be strictly adopted by all the healthcare facility providers to overcome these superbugs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
13
0
3

Year Published

2015
2015
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(18 citation statements)
references
References 1 publication
2
13
0
3
Order By: Relevance
“…All the isolates showed 100% sensitive to polymyxin B and colistin. [11] In this study, we have observed complete resistance to all the antibiotics tested except imipenem which showed 85% isolates were resistance, which is in concordance with other earlier studies, however, we did not include colistin in our study. A report by Aliskan et al, with 1071 MDRPA, reported resistance to imipenem (22.5%) and meropenem (31%).…”
Section: Discussionsupporting
confidence: 91%
“…All the isolates showed 100% sensitive to polymyxin B and colistin. [11] In this study, we have observed complete resistance to all the antibiotics tested except imipenem which showed 85% isolates were resistance, which is in concordance with other earlier studies, however, we did not include colistin in our study. A report by Aliskan et al, with 1071 MDRPA, reported resistance to imipenem (22.5%) and meropenem (31%).…”
Section: Discussionsupporting
confidence: 91%
“…P. aeruginosa is intrinsically resistant to several antimicrobial agents and has the capacity to acquire further resistance mechanisms (Ramakrishnan et al, 2014). The frequency of multidrug-resistant and pan-drug resistant strains of P. aeruginosa is high in ICUs and increases mortality, morbidity, and hospital costs (Hong et al, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…Yoğun bakım hastalarında ampirik tedavide karbapenemler, florokinolonlar ve üçüncü kuşak sefalosporinlerin kullanılması Pseudomonas gibi dirençli bakterilerin etken olduğu enfeksiyonların artmasına neden olmaktadır [4,14]. Özellikle yoğun bakım ünitelerinde çoklu ilaca dirençli P. aeuginosa suşlarının dünya genelinde artmakta olduğu bildirilmektedir [10,15].…”
Section: Gereç Ve Yöntemunclassified
“…Makrolidler, tetrasiklin, rifampin ve sefiksime karşı ise yüksek oranda direnç gösterir. Hızlı direnç gelişiminde rol oynayan mekanizmalar arasında beta-laktamaz üretimi, dış membran geçirgenliğinde azalma ve aktif pompalama sistemleri sayılabilir [3][4][5]. P. aeruginosa çoklu antibiyotik direnci gösterebilmesi ve kullanılan antimikrobiyal ajanlara karşı hızlı direnç geliştirebilmesi nedeniyle özelikle yoğun bakımda izlenen hastaların tedavilerinde sorunlara neden olmaktadır [6,7].…”
Section: Introductionunclassified